Exendin-(9-39) effects on glucose and insulin in children with congenital hyperinsulinism during fasting and during a meal and a protein challenge
Both modifications exist for the same reason, and this is the point most secondary descriptions get wrong by treating them as two unrelated features
Reddy IA, Pino JA, Weikop P, Osses N, Srensen G, Bering T, et al
The green list will help protect patients from unreliable, illegally compounded GLP-1s and simplify screening for border security
Its effectiveness varies with individual health, lifestyle, and concurrent therapies
While this is a single case report and not necessarily generalizable, it underscores why thyroid monitoring during GLP-1 therapy is not optional, it is essential